Peiyuan Yin

7.4k citations
98 papers · 6.0k indexed · 1 hit paper · h-index 42

Peiyuan Yin

97 papers receiving 5.9k citations

Hit Papers

Altered Lipid Metabolism in Recovered SARS Patients Twelv...3042017202620202023100200300

Peers

Peiyuan Yin
Comparison fields: 5 of 153
  • Cancer Research 1.1k
  • Spectroscopy 1.1k
  • Molecular Biology 4.1k
  • Complementary and alternative medicine 379
  • Biological Psychiatry 88
Replace Xinjie Zhao with:
Xinjie Zhao China
Mingming Su China
Tianlu Chen China
Yunping Qiu China
Aihua Zhao China
Richard D. Beger United States
Ben van Ommen Netherlands
Eric Chun Yong Chan Singapore
Martin Giera Netherlands
Guoxiang Xie China
Peiyuan Yin relative to Xinjie Zhao China Xinjie Zhao's profile →
Citations per field
00.5×1.6×
Xinjie Zhao · 1×
Citations per year

Countries citing papers authored by Peiyuan Yin

Since Specialization
Citations

This map shows the geographic impact of Peiyuan Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiyuan Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiyuan Yin more than expected).

Fields of papers citing papers by Peiyuan Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiyuan Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiyuan Yin. The network helps show where Peiyuan Yin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peiyuan Yin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peiyuan Yin Line = papers co-authored together Peiyuan Yin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202315
2 20236
3 202281
4 202211
5 2019107
6 201918
7 201935
8 201928
9 201831
10 201820
11 2017101
12 201648
13 201541
14 20149
15 2013342
16 201140
17 201039
18 2009189
19 2009177
20 200993

About Peiyuan Yin

Peiyuan Yin is a scholar working on Spectroscopy, Cancer Research and Molecular Biology, having authored 98 papers that have together received 6.0k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (66 papers), Liver Disease Diagnosis and Treatment (17 papers), Analytical Chemistry and Chromatography (14 papers), Cancer, Hypoxia, and Metabolism (14 papers), Cancer, Lipids, and Metabolism (10 papers), Mass Spectrometry Techniques and Applications (9 papers), Advanced Chemical Sensor Technologies (9 papers) and Gut microbiota and health (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Spectroscopy (1.1k citations) and Molecular Biology (4.1k citations). Peiyuan Yin has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Guowang Xu, Xin Lu, Xinjie Zhao, Lina Zhou, Rainer Lehmann, Hongwei Kong, Qiang Huang, Yexiong Tan, Hongyang Wang and Jing Chen. Their work appears in journals such as Scientific Reports, Journal of Proteome Research, Analytical Chemistry, Journal of Chromatography B and Analytical and Bioanalytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026